Medicare drug price negotiation closes, affordable drugs by 2026 nears

TL/DR –

The Inflation Reduction Act’s Medicare prescription drug price negotiation period has come to an end, marking a step towards more affordable drugs by 2026. The Act allows the government to negotiate lower drug prices, which could potentially save the government and American taxpayers billions of dollars annually. The hope is that the savings will be passed down to consumers, resulting in a significant decrease in prescription drug costs for individuals by 2026.

Inflation Reduction Act Moves Closer to Affordable Medicare Drugs by 2026

The Inflation Reduction Act‘s Medicare drug price neogtiation phase has now concluded. This significant milestone brings us one step closer to more affordable drugs by 2026.

—
Read More US Economic News